Renal Denervation and Hypertension

被引:45
作者
Schlaich, Markus P. [1 ]
Krum, Henry [2 ]
Sobotka, Paul A. [3 ,4 ]
Esler, Murray D. [1 ]
机构
[1] Alfred Hosp, Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis Lab, Melbourne, Vic, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia
[3] Hennepin Cty Med Ctr, Dept Cardiol, Minneapolis, MN 55415 USA
[4] ARDIAN Inc, Mountain View, CA USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
blood pressure; hypertension; renal denervation; sympathetic; SYMPATHETIC NERVOUS-SYSTEM; HEART-FAILURE; BLOOD-PRESSURE; RESISTANT HYPERTENSION; NEURAL-CONTROL; ARTERIAL-HYPERTENSION; SODIUM RETENTION; RENIN RELEASE; ONE-KIDNEY; DISEASE;
D O I
10.1038/ajh.2011.35
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Essential hypertension remains one of the biggest challenges in medicine with an enormous impact on both individual and society levels. With the exception of relatively rare monogenetic forms of hypertension, there is now general agreement that the condition is multifactorial in nature and hence requires therapeutic approaches targeting several aspects of the underlying pathophysiology. Accordingly, all major guidelines promote a combination of lifestyle interventions and combination pharmacotherapy to reach target blood pressure (BP) levels in order to reduce overall cardiovascular risk in affected patients. Although this approach works for many, it fails in a considerable number of patients for various reasons including drug-intolerance, noncompliance, physician inertia, and others, leaving them at unacceptably high cardiovascular risk. The quest for additional therapeutic approaches to safely and effectively manage hypertension continues and expands to the reappraisal of older concepts such as renal denervation. Based on the robust preclinical and clinical data surrounding the role of renal sympathetic nerves in various aspects of BP control very recent efforts have led to the development of a novel catheter-based approach using radiofrequency (RF) energy to selectively target and disrupt the renal nerves. The available evidence from the limited number of uncontrolled hypertensive patients in whom renal denervation has been performed are auspicious and indicate that the procedure has a favorable safety profile and is associated with a substantial and presumably sustained BP reduction. Although promising, a myriad of questions are far from being conclusively answered and require our concerted research efforts to explore the full potential and possible risks of this approach. Here we briefly review the science surrounding renal denervation, summarize the current data on safety and efficacy of renal nerve ablation, and discuss some of the open questions that need to be addressed in the near future.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 62 条
[1]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[2]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[3]  
BARAJAS L, 1978, FED PROC, V37, P1192
[4]   EFFECT OF RENAL SYMPATHETIC-NERVE STIMULATION ON PROXIMAL WATER AND SODIUM-REABSORPTION [J].
BELLOREUSS, E ;
TREVINO, DL ;
GOTTSCHALK, CW .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (04) :1104-1107
[5]   Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].
Black, HR ;
Elliott, WJ ;
Grandits, G ;
Grambsch, P ;
Lucente, T ;
White, WB ;
Neaton, JD ;
Grimm, RH ;
Hansson, L ;
Lacourcière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Anders, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082
[6]   Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension [J].
Burns, Joanna ;
Sivananthan, Mohan U. ;
Ball, Stephen G. ;
Mackintosh, Alan F. ;
Mary, David A. S. G. ;
Greenwood, John P. .
CIRCULATION, 2007, 115 (15) :1999-2005
[7]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[8]   RENAL AFFERENT DENERVATION PREVENTS HYPERTENSION IN RATS WITH CHRONIC-RENAL-FAILURE [J].
CAMPESE, VM ;
KOGOSOV, E .
HYPERTENSION, 1995, 25 (04) :878-882
[9]  
Campese VM, 1997, J NEPHROL, V10, P184
[10]   RENAL AFFERENT DENERVATION PREVENTS THE PROGRESSION OF RENAL-DISEASE IN THE RENAL ABLATION MODEL OF CHRONIC-RENAL-FAILURE IN THE RAT [J].
CAMPESE, VM ;
KOGOSOV, E ;
KOSS, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (05) :861-865